+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Ambulance Stretchers Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Emergency Stretchers, Transport Stretchers, Bariatric Stretchers, Neonatal & Pediatric Stretchers, Scoop & Basket Stretchers), By Technology (Electric-Powered/Battery-Powered Stretchers, Manual Stretchers, Hydraulic & Pneumatic Stretchers), By Material (Metal , Composite Materials), By End User (EMS Service Providers, Hospitals & Trauma Centers, Ambulatory Surgical Centers , Military & Disaster Relief Agencies) Companies, and Country Forecast, 2021 to 2034

Global Ambulance Stretchers Market size is forecast to increase from $2.69 Billion in 2026 to $3.57 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005527
Pages: 228 Pages

Ambulance Equipment Market Size, Share and Growth Outlook, 2026: Analysis By Equipment Type (Cardiac & Respiratory Equipment , Monitoring & Diagnostic Equipment , Patient Handling Equipment , Communication Equipment , Infection Control & PPE, Emergency Medicine & Fluid Management ), By Ambulance Type (Ground Ambulance, Air Ambulance , Water Ambulance), By Equipment Level (Basic Life Support , Advanced Life Support ), By End User (Hospital-based Emergency Services, Private EMS Providers, Government & Municipal Agencies, Military & Defense) Companies, and Country Forecast, 2021 to 2034

Global Ambulance Equipment Market size is forecast to increase from $6.01 Billion in 2026 to $8.07 Billion in 2034 at a CAGR of 3.76% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005526
Pages: 229 Pages

Ambient Assisted Living Market Size, Share and Growth Outlook, 2026: Analysis By Component (Hardware , Software , Services ), By System Function (Safety and Security , Health and Medical Monitoring , Communication and Connectivity , Mobility and Transport Assistive Systems, Lifestyle & Energy Management ), By Technology Platform (Smart Home and Building Automation, Telehealth and Telecare Systems, Wearable Health Technology, Social and Companion Robotics), By Deployment Model (Stand-Alone Residential Units, Assisted Living Facilities, Senior Care Homes & Nursing Homes, Hospitals and Specialized Clinics), By End-User (Elderly / Geriatric Individuals, Individuals with Disabilities & Chronic Illnesses, Professional Caregivers & Healthcare Providers) Companies, and Country Forecast, 2021 to 2034

Global Ambient Assisted Living Market size is forecast to increase from $12.31 Billion in 2026 to $35.61 Billion in 2034 at a CAGR of 14.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005525
Pages: 218 Pages

Alzheimer’s Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Disease-Modifying Therapies / Immunotherapies , Combination Drugs), By Disease Stage (Early-Stage Alzheimer's Disease / Mild Cognitive Impairment , Middle-Stage / Moderate Alzheimer's Disease, Late-Stage / Severe Alzheimer's Disease), By Route of Administration (Oral , Injectable , Transdermal Patches), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online / E-Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Alzheimer’s Therapeutics Market size is forecast to increase from $6.85 Billion in 2026 to $26.45 Billion in 2034 at a CAGR of 18.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005524
Pages: 212 Pages

Alternative Veterinary Medicine Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Alternative Pharmaceuticals , Nutritional Supplements & Nutraceuticals, Functional Feed Additives, Botanical Extracts & Essential Oils), By Animal Type (Companion Animals , Production / Livestock Animals ), By System of Medicine (Traditional Chinese Veterinary Medicine (TCVM), Ayurvedic Veterinary Medicine, Homeopathy & Electro-Homeopathy, Chiropractic & Osteopathic Medicine, Acupuncture & Laser Therapy), By Route of Administration (Oral , Topical , Injectable / Parenteral), By Distribution Channel (Veterinary Hospitals & Clinic Pharmacies, Retail Pet & Specialty Health Stores, E-Commerce / Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Alternative Veterinary Medicine Market size is forecast to increase from $4.38 Billion in 2026 to $11.16 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005523
Pages: 224 Pages

Alprazolam Market Size, Share and Growth Outlook, 2026: Analysis By Form (Immediate-Release Tablets, Extended-Release Tablets , Orally Disintegrating Tablets, Liquid ), By Application (Anxiety Disorders, Panic Disorders , Insomnia , Depression-associated Anxiety), By Supply Stream (Branded Medications, Generic Formulations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Alprazolam Market size is forecast to increase from $585.05 Million in 2026 to $819.35 Million in 2034 at a CAGR of 4.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005522
Pages: 223 Pages

Alpha-glucosidase Inhibitors Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Acarbose, Miglitol, Voglibose, Fixed-Dose Combination Drugs), By Indication (Type 2 Diabetes Mellitus, Pre-diabetes, Dumping Syndrome), By Drug Category (Generic Drugs, Branded Drugs), By Route of Administration (Oral Tablets, Orally Disintegrating Formulations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Alpha-glucosidase Inhibitors Market size is forecast to increase from $4.31 Billion in 2026 to $5.29 Billion in 2034 at a CAGR of 2.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005521
Pages: 223 Pages

Alpha-gal Syndrome Allergy Market Size, Share and Growth Outlook, 2026: Analysis By Offering (Diagnostics, Therapeutics ), By Drug Class (Epinephrine , Antihistamines, Corticosteroids), By Prescription Status (Prescription Drugs, Over-the-Counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Alpha-gal Syndrome Allergy Market size is forecast to increase from $98.21 Million in 2026 to $189.18 Million in 2034 at a CAGR of 8.54% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005520
Pages: 230 Pages

Alpha-1 Antitrypsin Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Plasma-derived Augmentation Therapy, Recombinant Alpha-1 Antitrypsin, Emerging Gene Therapies & RNA Interference , Synthetic Inhibitors), By Application (Alpha-1 Antitrypsin Deficiency , AATD-associated Liver Disease, Cystic Fibrosis, Type 1 Diabetes Management), By Route of Administration (Intravenous , Inhalation), By End User (Hospitals, Specialty Clinics, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Alpha-1 Antitrypsin Drugs Market size is forecast to increase from $2.63 Billion in 2026 to $3.98 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005519
Pages: 221 Pages

Alpha Emitter Market Size, Share and Growth Outlook, 2026: Analysis By Radionuclide Type (Radium-223, Actinium-225, Lead-212, Astatine-211, Bismuth-212 / Bismuth-213, Thorium-227, PMC - NIH), By Application (Prostate Cancer, Bone Metastasis, Neuroendocrine Tumors , Ovarian Cancer, Hematological Malignancies), By Technology (Targeted Alpha Therapy , Radioligand Therapy), By End User (Hospitals, Specialty Oncology Clinics, Nuclear Medicine Centers, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Alpha Emitter Market size is forecast to increase from $945.85 Million in 2026 to $2358.67 Million in 2034 at a CAGR of 12.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005518
Pages: 214 Pages